NCT05884723

Brief Summary

Non-alcoholic fatty liver disease is becoming increasingly common in Canada and throughout the world. Fatty liver can increase the risks of perioperative complications for those who need liver surgery. A ketogenic diet is low in carbohydrates and can be very effective in reducing liver fat content. The purpose of this randomized control trial is to compare the effect of a short duration (4 week) preoperative ketogenic diet on operative and disease outcomes in patients undergoing liver surgery. One arm will be randomized to the ketogenic diet and the other will receive standard of care pre-operative dietary consultation.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for not_applicable

Timeline
50mo left

Started May 2024

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress33%
May 2024Jul 2030

First Submitted

Initial submission to the registry

May 15, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

June 1, 2023

Completed
11 months until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2030

Expected
Last Updated

April 23, 2024

Status Verified

April 1, 2024

Enrollment Period

1.2 years

First QC Date

May 15, 2023

Last Update Submit

April 22, 2024

Conditions

Keywords

ketogenic dietNAFLDcolorectal liver metastases

Outcome Measures

Primary Outcomes (1)

  • Perioperative blood transfusion

    receipt (binary) of packed red blood cell (pRBC) units intraoperatively and during the immediate postoperative time period (POD 0 - 7)

    postoperative days 0-7

Secondary Outcomes (15)

  • Amount of perioperative blood transfusion

    postoperative days 0-7

  • Intraoperative blood loss

    Operative period

  • Steatosis

    Time of primary surgery

  • Change in steatosis

    ~6 weeks

  • Operative time

    During primary surgery

  • +10 more secondary outcomes

Study Arms (2)

Ketogenic Diet Arm

EXPERIMENTAL

Participants in this group will be counselled by a registered dietician and then undergo a 4-week preoperative well formulated ketogenic diet. They will record all nutritional uptake during the diet using an app called Cronometer and provide weekly summary reports to the study team.

Dietary Supplement: Ketogenic Diet

Control Arm

NO INTERVENTION

Participants in this group will be counselled by a registered dietician and then undergo a 4-week standard of care diet, as recommended by Canada's Food Guide. They will record all nutritional uptake during the diet using an app called Cronometer and provide weekly summary reports to the study team.

Interventions

Ketogenic DietDIETARY_SUPPLEMENT

4-week preoperative well-formulated very low carbohydrate isocaloric diet consisting of 50g net daily carbohydrates and 1.5g/kg protein with the remaining energy needs consisting of primarily mono- and polyunsaturated fats

Ketogenic Diet Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients 18 years of age or older undergoing any type of liver resection (e.g. wedge, formal hepatectomy), either open or laparoscopic, for colorectal liver metastases (CRLM)
  • Patients with evidence of hepatic steatosis on pre-operative imaging (CT or MR) or biopsy.
  • Ability to use an app based nutritional program to track macronutrient uptake throughout the dietary intervention.

You may not qualify if:

  • Patients undergoing liver resection for any other indication
  • Patients on sodium glucose co-transporter 2 (SGLT-2) inhibitors (these are contraindicated with a ketogenic diet).
  • Patients without evidence of hepatic steatosis.
  • Patients with evidence of liver fibrosis or cirrhosis on preoperative bloodwork or imaging.
  • Patients with alcohol-related hepatic steatosis.
  • Patients with a known bleeding disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Fatty LiverNon-alcoholic Fatty Liver Disease

Interventions

Diet, Ketogenic

Condition Hierarchy (Ancestors)

Liver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Diet, Carbohydrate-RestrictedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Anton Skaro, MD PhD

    London Health Sciences Centre/Lawson Health Research Institute

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anton Skaro, MD PhD

CONTACT

Crystal Engelage, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
The surgeons, surgical team, and data abstractors will be blinded to participant randomization
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: preoperative ketogenic diet group vs control standard of care preoperative diet
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2023

First Posted

June 1, 2023

Study Start

May 1, 2024

Primary Completion

July 1, 2025

Study Completion (Estimated)

July 1, 2030

Last Updated

April 23, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share